Literature DB >> 7480519

State-dependent effects of atypical benzodiazepine-receptor agonists.

A Jackson1.   

Abstract

The state-dependent effect of the BZ-receptor agonist diazepam (1.25-10 mg/kg), the partial agonist FG 8205 (0.5-4.0 mg/kg) and the BZ1-receptor agonist zolpidem (0.25-2 mg/kg) were investigated in rats. During daily sessions, animals were trained to acquire FR10 lever pressing for food reinforcement whilst under the influence of the agonists, using an operant technique. Forty-eight hours after the final training session under drug, their performance of the FR10 was evaluated during a test session, carried out following vehicle administration only. Neither diazepam, nor FG 8205 impaired acquisition of the task. In the group treated with 2 mg/kg zolpidem, six out of eight rats failed to learn within 20 sessions, but the smaller doses were without effect on acquisition. When drug treatment was withdrawn, there was evidence that all three of the agonists tested produced state-dependency. This was apparent in the form of longer latencies to obtain reinforcement and decreased lever pressing rates. The significance of these findings are discussed in the context of the relationship between the state-dependent effects of BZ-receptor agonists and their other properties, and the receptor subtypes which might underly these effects.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7480519     DOI: 10.1007/bf02245855

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Type I and type II GABAA-benzodiazepine receptors produced in transfected cells.

Authors:  D B Pritchett; H Lüddens; P H Seeburg
Journal:  Science       Date:  1989-09-22       Impact factor: 47.728

2.  Amnesic effects of diazepam: "drug dependence" explained by state-dependent learning.

Authors:  H H Jensen; J C Poulsen
Journal:  Scand J Psychol       Date:  1982

Review 3.  The behavioral profile of zolpidem, a novel hypnotic drug of imidazopyridine structure.

Authors:  D J Sanger; G Perrault; E Morel; D Joly; B Zivkovic
Journal:  Physiol Behav       Date:  1987

4.  Investigation of the development of tolerance to the actions of zolpidem and midazolam.

Authors:  D J Sanger; B Zivkovic
Journal:  Neuropharmacology       Date:  1987-10       Impact factor: 5.250

Review 5.  Novel anxiolytics that act as partial agonists at benzodiazepine receptors.

Authors:  W Haefely; J R Martin; P Schoch
Journal:  Trends Pharmacol Sci       Date:  1990-11       Impact factor: 14.819

6.  Differences in pharmacological profiles of a new generation of benzodiazepine and non-benzodiazepine hypnotics.

Authors:  G Perrault; E Morel; D J Sanger; B Zivkovic
Journal:  Eur J Pharmacol       Date:  1990-10-23       Impact factor: 4.432

7.  Time dependent pentylenetetrazol-like cues subsequent to diazepam administration.

Authors:  R J Barrett; R L Smith
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

8.  Amnesic trace locked into the benzodiazepine state of memory.

Authors:  F C Colpaert
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  An investigation into the discriminative stimulus and reinforcing properties of the CCKB-receptor antagonist, L-365,260 in rats.

Authors:  A Jackson; D Tattersall; G Bentley; W Rycroft; A Bourson; R Hargreaves; M Tricklebank; S Iversen
Journal:  Neuropeptides       Date:  1994-05       Impact factor: 3.286

10.  The pharmacological properties of the imidazobenzodiazepine, FG 8205, a novel partial agonist at the benzodiazepine receptor.

Authors:  M D Tricklebank; T Honoré; S D Iversen; J A Kemp; A R Knight; G R Marshall; N M Rupniak; L Singh; S Tye; F Watjen
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

View more
  2 in total

1.  Effects of zolpidem on sedation, anxiety, and memory in the plus-maze discriminative avoidance task.

Authors:  Karina A Zanin; Camilla L Patti; Leandro Sanday; Luciano Fernandes-Santos; Larissa C Oliveira; Dalva Poyares; Sergio Tufik; Roberto Frussa-Filho
Journal:  Psychopharmacology (Berl)       Date:  2012-06-23       Impact factor: 4.530

Review 2.  Social anxiety disorder : current treatment recommendations.

Authors:  Jacqueline E Muller; Liezl Koen; Soraya Seedat; Dan J Stein
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.